Download PDF
Thromb Haemost 1964; 11(02): 305-316
DOI: 10.1055/s-0038-1654831
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Investigations on Adenosine Diphosphate (ADP) Induced Platelet Adhesiveness in Vitro* Part II. Studies on the Mechanism

B. A Skålhegg
1   Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway. Head: P. A. Owren, M. D
,
A. J Hellem
1   Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway. Head: P. A. Owren, M. D
,
A. E Ödegaard
1   Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway. Head: P. A. Owren, M. D
› Author AffiliationsThe investigation was supported by The Norwegian Council on Cardiovascular Diseases.
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Also available at
    Permissions and Reprints

Summary

An attempt to clarify the ADP platelet reaction has been done by investigating the effect of substances which inhibit the reaction in vitro. The inhibitors used may be divided into two groups. Monoiodo acetic acid, molecular iodine, para-chloro mercuribenzoic acid and potassium ferricyanid lead to noncompetitive inhibition. Substances containing free -SH groups and adenine conjugates show competitive inhibition.

The primary bleeding time is prolonged when wounds are flushed with solutions of these compounds.

It is shown that adenosine tetraphosphate aggregates platelets in the same manner as ADP.

Based upon these observations an attempt is made to explain some of the steps involved in the ADP platelet reaction.

 

  • References

  • 1 Gaarder A. M, Jonsen J, Laland S, Hellem A. J, Owren P. A. Adenosine disphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 192: 531 1961;
    CrossrefPubMedSearch in Google Scholar
  • 2 Gross R. Metabolic aspects of normal and pathological platelets. Henry Ford Hosp. Intern. Symp. Blood Platelets, Detroit, March 1960. Little, Brown and Co.; Boston, Mass.:
  • 3 Fanti P. Thiol groups of blood platelets in relation to clot retraction. Nature 198: 95 1963;
    CrossrefPubMedSearch in Google Scholar
  • 4 Hellem A. J. The adhesiveness of human blood platelets in vitro. Thesis. Scand. J. clin. Lab. Invest.. 12. suppl. 51 1960
    PubMedSearch in Google Scholar
  • 5 Hellem A. J. The influence of adenosine diphosphate (ADP) on platelet adhesiveness in vitro. Vase. Symposium biological aspects of occlusive Vascular Disease, Cambridge. 1962 (In press).
    PubMedSearch in Google Scholar
  • 6 Hellem A. J, Ödegaard A. E, Skâlhegg B. A. Investigations on adenosine diphosphate (ADP) induced platelet adhesiveness in vitro. Part I. The ADP induced reaction in various experimental conditions. Thrombos. Diathes. haemorrh. (Stuttg) 10: 61 1963;
    PubMedSearch in Google Scholar
  • 7 Hellem A. J, Owren P. A. The mechanism of the hemostatic function of blood platelets. IX. Congr. Europ. Soc. Haemat., Lisboa. 1963
    PubMedSearch in Google Scholar
  • 8 Laland S. G. Personal communications..
    PubMed
  • 9 Lüscher E. F. Biochemische Eigenschaften und physiologische Bedeutung der Blutplättchen. Schweiz, med. Wschr. 89: 1021 1959;
    PubMedSearch in Google Scholar
  • 10 Nilsson I. M, Blombäck M, Jorpes E, Blombäck B, Johansson S. A. Von Willebrand’s disease and its correction with human plasma fraction 1-0. Acta med. scand. 159: 179 1957;
    PubMedSearch in Google Scholar
  • 11 Robinson L, Wagner R, Brinkhous K. M. Effect of SH-inhibitors on thrombin and ADP-induced platelet agglutination. Fed. Proc. Abstr. 47th Annual Meeting, Atlantic City; New Jersey: 20 1963
    Search in Google Scholar
  • 12 Zucker M. B. In vitro abnormality of the blood in von Willebrand’s disease correctable with normal plasma. Nature 197: 601 1963;
    CrossrefPubMedSearch in Google Scholar
  • 13 Ödegaard A. E, Skâlhegg B. A, Hellem A. J. Increased activity of “Anti-Willebrand Factor” in diabetic plasma. Thrombos. Diathes. haemorrh. (Stuttg) 11: 27 1964;
    PubMedSearch in Google Scholar